Why PCVX? Vaxcyte, Inc. Analysis, Price & AI Insights | Whystock
PCVX
$55.64-2.85 (-4.87%)
Pre-Market$56.35+0.71 (+1.28%)· Last close May 5
Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.